James Nagarajah
0000-0002-3555-0809
Radboudumc
72 papers found
Refreshing results…
Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasia by FDG-PET: Feasibility of a metabolic grading system
Lack of Somatostatin Receptor Subtype-2 (SSTR2) in the Normal Human Thyroid Gland at Protein Level: Apparent Discrepancy of Immunohistochemistry and Gender-Specific Uptake of 68Ga-DOTATOC?
Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate
Evaluation of the PET component of simultaneous [18F]choline PET/MRI in prostate cancer: comparison with [18F]choline PET/CT
Spatial Reconstruction of Human Thyroid based on Ultrasound and CT Image Data Fusion
Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors
18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma:
Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trials.
Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: Predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies
Phase I trial of panobinostat (P) and imatinib (IM) in patients with treatment-refractory gastrointestinal stromal tumors (GIST).
Ultrasound-Guided Fine-Needle Aspiration Biopsy of Clinically Suspicious Thyroid Nodules with an Automatic Aspirator: A Novel Technique
Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients
Effects of Rosiglitazone on Radioiodine Negative and Progressive Differentiated Thyroid Carcinoma as Assessed by 124I PET/CT Imaging
Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma
124I-PET/CT images of differentiated thyroid cancer patients
Real time US-guided biopsy of thyroid nodules response
18F-fluoride PET/CT for bone scanning
Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octrotate
Assay-Abhängigkeit der Calcitonin- Zielbereiche für „biochemisch geheilte“ Patienten mit medullärem Schilddrüsenkarzinom
Effects of dose inhomogeneities on normal tissue complication probability (NTCP) after Y-90 SIRT
Missing publications? Search for publications with a matching author name.